CK-0045 induced exposure-dependent reductions in body weight and improvement of key metabolic parameters in participants with obesity Data support advancement of CK-0045 into Phase 2 proof-of-concept studies in individuals with type 2 diabetes and/or obesity COPENHAGEN, Denmark, July 23,…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.